Wang Si-Ping, Wei Shu-Ning, Qi Jun-Yuan, Liu Xu-Ping, Yang Hong-Le, Zhao Jia-Wei, An Gang, Wang Jian-Xiang
Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):533-6.
To investigate clinical and laboratory characteristics of acute myeloid leukemia (AML) patients with t(7;11)(p15;p15).
Eleven patients with t(7;11)(p15;p15) were retrospectively reviewed involved in cell morphology, immunophenotype, cytogenetics as well as clinical features and prognosis.
Eight patients out of the eleven were female, six patients were AML-M2a, two M4, two M5, and one M6. All the 11 cases expressed CD33, 10 expressed CD117 and CD13, HLA-DR and CD34 was expressed in 7 and 6 patients, respectively. Karyotypes of all the patients were t(7;11) (p115;p15), additional trisomy 8 were found in only one patient. FLT3-ITD was positive in one of nine patients who were analysed for FLT3-ITD and FLT3-TKD. Two patients were alive, and one lost to followed up, while the rest of eight were dead.
The t(7;11) (p15;p15) abnormalities is one of rare chromosomal translocation in patients with AML. AML patients with t(7;11) (p15;p15) have clinical features of anemia, thrombocytopenia, higher white blood cell, and poor prognosis.
探讨伴有t(7;11)(p15;p15)的急性髓系白血病(AML)患者的临床及实验室特征。
回顾性分析11例伴有t(7;11)(p15;p15)的AML患者的细胞形态学、免疫表型、细胞遗传学以及临床特征和预后。
11例患者中8例为女性,6例为AML-M2a,2例为M4,2例为M5,1例为M6。11例均表达CD33,10例表达CD117和CD13,7例和6例分别表达HLA-DR和CD34。所有患者的核型均为t(7;11)(p115;p15),仅1例患者发现额外的8号染色体三体。在9例进行FLT3-ITD和FLT3-TKD分析的患者中,1例FLT3-ITD阳性。2例存活,1例失访,其余8例死亡。
t(7;11)(p15;p15)异常是AML患者中罕见的染色体易位之一。伴有t(7;11)(p15;p15)的AML患者具有贫血、血小板减少、白细胞升高及预后差的临床特征。